COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd. Announcement on the Dissolution of Shareholder Equity and Re-Pledge

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-031

Jilin Zixin Pharmaceutical Co., Ltd.

Announcement on the dissolution of shareholder pledge and re-pledge

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

On August 21, 2013, the company received the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company) Notice: Kangping Company pledged to China Construction Bank Co., Ltd. Tonghua Branch on July 27, 2012 (hereinafter referred to as : CCB Tonghua Branch) The company's 60 million shares of unrestricted shares (accounting for 11.70% of the company's total share capital) were processed on August 20, 2013 at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. On the same day, Kangping Company pledges the above shares to CCB Tonghua Branch again, and has gone through the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period is from August 20, 2013 to the pledgee to release the pledge. The date of registration.

 

Kangping Company holds a total of 251,475,016 shares of the company, of which 10,250,000 shares have been engaged in an agreed repurchase transaction. As of the date of this announcement, Kangping Company has plucked 240,430,000 shares of the Company (accounting for 95.61% of the shares held by Kangping Company), accounting for 46.87% of the company's total share capital.

 

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

August 23, 2013